Virbac: sales up 4.6% in 2023
Full-year sales were driven in particular by record fourth-quarter sales of 321 ME (+9.1% as reported and +10.6% at constant exchange rates and scope of consolidation).
Virbac confirms its sales growth target for 2024 of between 4% and 6% at constant exchange rates and scope of consolidation, as well as a ratio of operating income before amortization of assets acquired through acquisitions (adjusted Ebit) to sales of around 15% at constant exchange rates.
We reaffirm our ambition to achieve an EBITDA ratio of 20% by 2030", adds Virbac.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction